Introduction of CALR and JAK2 V617F mutations to UT-7/Epo and K562 by the CRISPR/Cas9 system

Shunichiro Yasuda

Presentation information

Oral Session

Oral Session 1-13A MPN: Basic (1)

Fri. Oct 12, 2018 9:00 AM - 10:00 AM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Takuro Kameda (Gastroenterology hematology, Faculty of Medicine, University of Miyazaki, Japan)

【Ｅ】

[OS1-13A-4] Introduction of CALR and JAK2 V617F mutations to UT-7/Epo and K562 by the CRISPR/Cas9 system

Shunichiro Yasuda^1,2, Satoru Aoyama^1,2, Daisuke Watanabe^1,2, Marito Araki³, Norio Komatsu⁴, Osamu Miura², Norihiko Kawamata^1,2 (1.Department of Immunotherapy for Hematopoietic Disorders, Tokyo, Japan, 2.Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan, 3.Transfusion Medicine and Stem Cell Regulation, Juntendo University, Tokyo, Japan, 4.Department of Hematology, Juntendo University, Tokyo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.